Literature DB >> 7688033

The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn.

J L Chu1, J Drappa, A Parnassa, K B Elkon.   

Abstract

Fas is a cell surface protein of the tumor necrosis factor receptor, nerve growth factor receptor, CD40 family, and is involved in the control of lymphocyte apoptosis. A mutation in the Fas gene in MRL/lpr mice results in massive lymphoproliferation (lpr) and accelerated autoimmunity. To further study the nature of this defect, Fas mRNA expression was evaluated by reverse transcriptase polymerase chain reaction as well as by Northern blotting. These studies revealed that the wild-type Fas message was produced at approximately 10-fold lower levels in the lpr compared with the ++ substrain of MRL mice. In addition to the wild-type transcript, lpr mice also synthesized chimeric transcripts containing an insertion of the early retrotransposon (ETn). Molecular cloning and nucleotide sequencing of a Fas-ETn chimeric cDNA suggested that the striking reduction in wild-type Fas mRNA levels and the presence of aberrant transcripts in MRL/lpr mice are most likely explained by the insertion of the ETn retrotransposon into an intron of the Fas gene and induction of alternative splicing involving the 5' ETn long terminal repeat.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688033      PMCID: PMC2191101          DOI: 10.1084/jem.178.2.723

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  Nucleotide sequence and evolution of ETn elements.

Authors:  P Sonigo; S Wain-Hobson; L Bougueleret; P Tiollais; F Jacob; P Brûlet
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

2.  A method for biotinylating oligonucleotide probes for use in molecular hybridizations.

Authors:  L K Riley; M E Marshall; M S Coleman
Journal:  DNA       Date:  1986-08

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  Early differential tissue expression of transposon-like repetitive DNA sequences of the mouse.

Authors:  P Brûlet; M Kaghad; Y S Xu; O Croissant; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

5.  Induction of various autoantibodies by mutant gene lpr in several strains of mice.

Authors:  S Izui; V E Kelley; K Masuda; H Yoshida; J B Roths; E D Murphy
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

6.  Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice.

Authors:  M Adachi; R Watanabe-Fukunaga; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

7.  The influence of the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains.

Authors:  R W Warren; S A Caster; J B Roths; E D Murphy; D S Pisetsky
Journal:  Clin Immunol Immunopathol       Date:  1984-04

8.  Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset.

Authors:  H C Morse; W F Davidson; R A Yetter; E D Murphy; J B Roths; R L Coffman
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Improved free-energy parameters for predictions of RNA duplex stability.

Authors:  S M Freier; R Kierzek; J A Jaeger; N Sugimoto; M H Caruthers; T Neilson; D H Turner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more
  55 in total

Review 1.  Influence of hypoxia in inflammatory synovitis.

Authors:  T Bodamyali; C R Stevens; M E Billingham; S Ohta; D R Blake
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

Review 2.  Genetics of SLE in mice.

Authors:  Dwight H Kono; Argyrios N Theofilopoulos
Journal:  Springer Semin Immunopathol       Date:  2006-09-14

Review 3.  Modification of accessory molecule signaling.

Authors:  Mary K Crow
Journal:  Springer Semin Immunopathol       Date:  2006-05-16

Review 4.  The Fas signaling connection between autoimmunity and embryonic lethality.

Authors:  H C Hsu; Y Matsuki; H G Zhang; T Zhou; J D Mountz
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

Review 5.  Regulation of apoptosis in immune cells.

Authors:  J D Mountz; T Zhou; J Wu; W Wang; X Su; J Cheng
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

6.  Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression.

Authors:  L B Owen-Schaub; W Zhang; J C Cusack; L S Angelo; S M Santee; T Fujiwara; J A Roth; A B Deisseroth; W W Zhang; E Kruzel
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

7.  Proliferation of CD3+ B220- single-positive normal T cells was suppressed in B-cell-deficient lpr mice.

Authors:  T Akashi; S Nagafuchi; K Anzai; D Kitamura; J Wang; I Taniuchi; Y Niho; T Watanabe
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

8.  Effects of low-dose-gamma rays on the immune system of different animal models of disease.

Authors:  Noriko Shimura; Shuji Kojima
Journal:  Dose Response       Date:  2014-04-23       Impact factor: 2.658

9.  Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors.

Authors:  Dawei Liu; Xiaoxing Kou; Chider Chen; Shiyu Liu; Yao Liu; Wenjing Yu; Tingting Yu; Ruili Yang; Runci Wang; Yanheng Zhou; Songtao Shi
Journal:  Cell Res       Date:  2018-07-20       Impact factor: 25.617

Review 10.  Dysregulation of T Follicular Helper Cells in Lupus.

Authors:  John D Mountz; Hui-Chen Hsu; Andre Ballesteros-Tato
Journal:  J Immunol       Date:  2019-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.